ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.3636A>G (p.Ser1212=) (rs148038877)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000494812 SCV000578220 likely benign Breast-ovarian cancer, familial 1 2017-06-29 reviewed by expert panel curation Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/).
GeneDx RCV000123913 SCV000167295 benign not specified 2014-02-24 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Ambry Genetics RCV000163075 SCV000213574 likely benign Hereditary cancer-predisposing syndrome 2014-10-08 criteria provided, single submitter clinical testing
Invitae RCV000588372 SCV000253501 likely benign not provided 2019-02-18 criteria provided, single submitter clinical testing
Color RCV000163075 SCV000688443 likely benign Hereditary cancer-predisposing syndrome 2016-08-15 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000588372 SCV000699048 likely benign not provided 2016-08-28 criteria provided, single submitter clinical testing Variant summary: The BRCA1 c.3636A>G (p.Ser1212Ser) variant causes a synonymous change involving a non-conserved nucleotide with 4/5 splice prediction tools predict no significant impact on splicing. A functional study by minigene assay reports that it was one of the variants that did not dramatically alter splicing through disruption of an ESE (Anczukow_2008). The exact extent of functional impairment was not provided in the study. The variant of interest was found in controls with an allele frequency of 1/121208, which does not exceed the maximum expected allele frequency for a pathogenic BRCA1 variant (1/1000). It has also been reported in individuals from HBOC families (Judkins_2005, Anczukow_2008); however with limited information (i.e. no co-occurrence and cosegregation data provided). Multiple clinical laboratories and reputable databases cite the variant as "likely benign/benign." Therefore, taken all available lines of evidence into consideration, the variant of interest has been classified as likely benign until additional information becomes available.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.